Our mission is to help you to live well, and to live well with Botaani.
We are founders of a disruptive health and wellness company. We believe everyone has the right to live well and quite simply our mission is for everyone to live well with Botaani.
Our manufactured product Botaani Cannafusion sets the gold standard in optimal high-resin, whole plant cannabis concentrates and we are proud to offer it to you.
Our founder is a Master Grower. His expertise and experience has guided the cultivation of each plant from the first green shoot through to the first harvest.
We pride ourselves on achieving top-shelf quality.
Botaani is the trading name of Global Health Wellness Jersey SA LTD.
The business is wholly owned by the team, so you know that each of us is vested in getting everything right for you, every stage of the way.
Our corporate office is located in Jersey, Channel Islands.
We opened for business on 20 April 2022.
A brief history of the medicinal use of the cannabis plant….
Our Botaani Cannafusion concentrate is brought to you with a long heritage, that dates back to the early records of the ‘father of Chinese Medicine’, when medicinal cannabis was listed in 2,800 BC in the Emperor Shen Nung’s pharmacopoeia.
Mentions of the potency of the plant and its therapeutic benefits then appeared in Egyptian, Japanese, Indian, Hindu, Assyrian, Greek and Roman texts. Skip forward to the 1800s in Britain and it was allegedly being heralded by Queen Victoria as her preferred form of pain relief for menstrual cramps. At this point cannabis had established itself as a common treatment for a vast array of health problems, including arthritis, rabies, cholera, convulsions, digestive problems, amenorrhea, child-birth, female conditions, toe-nail problems, eye problems, migraines, anxiety, depression, inflammation, pain, lack of appetite and asthma. Importantly, the use of cannabis is recorded in conjunction with statements that suggest moderate use of the plant may be made with virtually no ill effects.
About the same time, in the former colonies of Great Britain and other European countries, the criminalisation of cannabis began. Prohibition began in the US in 1911. In 1928, Britain followed suite and criminalised the plant, a move widely regarded now as having been fuelled by underlying racism. Similar legislation was introduced in other jurisdictions in Europe and across America, and with this criminalisation, led to the medical profession losing interest in the potential benefits of the cannabis plant. Although limited hemp varieties continue to be legal in many places, the use of cannabis became viewed as amoral and a social ill.
This remained the position largely in Britain until the cases of two epileptic children who benefited from using cannabis caught the public’s imagination. Public pressure led to a change in the law and the medicinal use of cannabis was once again permitted in Britain in 2018 (albeit with significant restrictions). Changes to the statutory position of cannabis in other jurisdictions has become widespread with steps being taken to decriminalise cannabis for medicinal and recreational cannabis use, right through to the legalisation of certain CBD isolates.
The human endocannabinoid system and the role of the cannabis plant….
In the background, research into the potential potency of the plant had continued but without significant political support or funding. Researchers in the US had established, that certain cannabinoids had the ability to shrink cancerous tumours, improve the health of Aids patients and assist the respiratory position of patients with chronic pulmonary lung disease.
One of the most significant discoveries took place in Israel in 1964. Dr Raphael Mechoulam at the Hebrew University of Jerusalem, had been leading research into the medicinal effects of certain plants. His research led to the isolation of tetrahydrocannabinol (THC) from the plant and the identification of its psychoactive properties. In 1988, the quest to understanding how THC worked on the human brain, led Dr Alleyn Howlett at Saint Louis University Medical School to discover the first cannabinoid receptor, now known as Cannabinoid 1(CB1). With this discovery came the understanding that receptors act like a lock on a cell membrane. When a certain chemical key binds itself to a receptor, it triggers a chemical reaction in the cell, resulting in a change in the message the cell sends. With this discovery came an understanding of how THC affected a biological change in the body. Scientists hypothesised that the receptor within the human body was not there for the THC key from the plant, but rather for a human cannabis like key that worked at the same receptor site. Discoveries over the next decade led to the identification of other internal cannabis like compounds, which became known as inner cannabinoids or “endo” (Greek for inside) -cannabinoids. The identification of a second cannabinoid receptor, known as Cannabinoid 2 (CB2) and the first identified CB1, and endocannabinoids all led to a huge resurgence in interest in the cannabis plant’s ability to produce phyto-cannabinoids* (cannabinoids found within the plant) to alter the chemical messages sent within the human endocannabinoid system.
Scientists now understand that the function of the endocannabinoid system is to regulate the flow of chemical messages sent between human cells. They have also generally agreed that while they don’t quite understand what CBD actually does in the body, they are of the opinion that it does not ignite the CB1 and CB2 receptors in the same way that THC does. The endocannabinoid system responds to stress, illness, inflammation and infection indicators triggering a response and endocannabinoids are released by the cells in order to restore homeostasis in the body. They function by attaching to the CB1 or CB2 receptors in the human body, instructing a cell to change the message it is sending in order to restore the homeostatis in the body and thereby fix the potential ailment. However, if the body’s endocannabinoid system fails and is not messaging correctly, it may be unable to fix this failure and could result in an inflammation, illness or a medical condition. Pharmaceutical medication available to treat the illness or condition the patient presents with. With modern day’s continual on slaught of pressures and man made toxins in our lives, our systems are struggling and therefore mostly failing to maintain homeostatis, and we find ourselves turning to treating the symptoms instead of treating or preventing the potential cause.
Practically all functions of the human body are regulated through the cannabinoid system, including, but not limited to:
- Immune function
- Hormone regulation
- Pain sensation
- Inflammatory response
- Inhibition of cancerous cells
- Maintenance of bone mass
- Cardiovascular function
- Gastrointestinal activity
- Protection of neurons
The excitement around the potential medicinal benefit of the cannabis plant, comes from the fact that the plant has the potential to support and aid the body’s endocannabinoid system should it fail.
Cannabinoids found in the plant have the power to replicate the healthy function of the endocannabinoids found in the human body. Some scientists believe that in this way the cannabis plant may have the ability to fix a failure in the regulation of a function within the human body “at source” as it were and in so doing restore the balance in the human body and possibly with little or no ill side effects.
If these scientists are correct, cannabis medicine has the potential to transform human health in ways we cannot simply yet imagine.
*Scientists have discovered an abundance of phyto-cannabinoids in the cannabis plant and in other plants such as licorice, pine, rhododendron, echinacea, helichrysum (sun flowers) and radula (liverworts).